How many stocks are there of MorphoSys?
The current number of stocks of MorphoSys is 34.31 M undefined.
MorphoSys Stocks 2024
MorphoSys Stocks
34.31 M
MorphoSys Dividend yield
Ticker
MOR.DE
ISIN
DE0006632003
WKN
663200
In 2024, MorphoSys had 34.31 M outstanding stocks, a 0% change from the 34.31 M stocks in the previous year.
The MorphoSys Stocks history
| YEAR | NUMBER OF STOCKS (undefined EUR) |
|---|---|
| 2030e | 34.31 |
| 2029e | 34.31 |
| 2028e | 34.31 |
| 2027e | 34.31 |
| 2026e | 34.31 |
| 2025e | 34.31 |
| 2024e | 34.31 |
| 2023 | 34.31 |
| 2022 | 34.16 |
| 2021 | 33.4 |
| 2020 | 33.17 |
| 2019 | 31.61 |
| 2018 | 31.34 |
| 2017 | 28.95 |
| 2016 | 26.44 |
| 2015 | 26.24 |
| 2014 | 25.9 |
| 2013 | 24.8 |
| 2012 | 23.3 |
| 2011 | 22.9 |
| 2010 | 22.8 |
| 2009 | 22.6 |
| 2008 | 22.3 |
| 2007 | 21.6 |
| 2006 | 19.4 |
| 2005 | 17 |
| 2004 | 15.5 |
MorphoSys Aktienanalyse
What does MorphoSys do?
MorphoSys AG is a biotech company based in Planegg near Munich, Germany, founded in 1992. The company specializes in the discovery and development of therapeutic antibodies and operates worldwide. MorphoSys ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating MorphoSys's Shares Outstanding
MorphoSys's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in MorphoSys’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding MorphoSys’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in MorphoSys’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about MorphoSys Stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of MorphoSys are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of MorphoSys evolved in recent years?
The number of shares of MorphoSys has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. MorphoSys as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of MorphoSys?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does MorphoSys pay?
Over the past 12 months, MorphoSys paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MorphoSys is expected to pay a dividend of 0 EUR.
What is the dividend yield of MorphoSys?
The current dividend yield of MorphoSys is .
When does MorphoSys pay dividends?
MorphoSys pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of MorphoSys?
MorphoSys paid dividends every year for the past 0 years.
What is the dividend of MorphoSys?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is MorphoSys located?
MorphoSys is assigned to the 'Health' sector.
Wann musste ich die Aktien von MorphoSys kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of MorphoSys from 4/30/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 4/30/2024.
When did MorphoSys pay the last dividend?
The last dividend was paid out on 4/30/2024.
What was the dividend of MorphoSys in the year 2023?
In the year 2023, MorphoSys distributed 0 EUR as dividends.
In which currency does MorphoSys pay out the dividend?
The dividends of MorphoSys are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The MorphoSys stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von MorphoSys
Our stock analysis for MorphoSys Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MorphoSys Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
